Inhaled cidofovir dry-powder formulation for postexposure prophylaxis and treatment of smallpox
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272200900015C
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,008,317
Award facts
- Opportunity
-
- Inhaled Cidofovir Dry-Powder Formulation for Postexposure Prophylaxis and Treatment of Smallpox Award Notice · Posted Aug 17, 2009
- Contract value 42% obligated
- $31,006,981.93 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 35 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$80,805 | |
| Other Administrative Action | -$0 | |
| Funding Only Action | $155,864 | |
| Funding Only Action | $6,431,950 | |
| Original award | $6,420,503 |
About this award
This is a $31,006,981.93 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) for the development of an inhaled dry-powder formulation of the antiviral drug cidofovir. The contract is for the postexposure prophylaxis and treatment of smallpox and was not set aside for any special business designation. Resilience has previously performed other chemical, biological, and pharmaceutical manufacturing work for the Department of Defense and Department of Health and Human Services. This contract appears to be part of a larger portfolio of acquisition vehicles Resilience holds with the Department of the Army, including an IDIQ for medical countermeasure development and an IDIQ for FDA-approved products supporting chemical and biological defense programs.
Quick answers
Who was awarded contract HHSN272200900015C?
HHSN272200900015C was awarded to Resilience Government Services, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on August 15, 2009.
How much is contract HHSN272200900015C worth?
The government has obligated $13,008,317 on HHSN272200900015C. Its current value, with exercised options, is $31,006,982.
Was contract HHSN272200900015C competed?
The extent of competition for HHSN272200900015C was full and open competition. The government received 35 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award